Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Susan Mugaba
Observed names:
S Mugaba,
S. Mugaba
Institutions:
MRC/UVRI & LSHTM Uganda Research Unit,
Medical Research Council,
Uganda Virus Research Institute
Observed institutions:
London School of Hygiene & Tropical Medicine,
MRC/UVRI & LSHTM Uganda Research Unit,
Medical Research Council,
Uganda Virus Research Institute
ORCID:
0009-0000-3944-6294
Observed ORCID:
0009-0000-3944-6294
OpenAlex ID:
A5036257484
Interferon gamma (IFN-γ) negative CD4+ and CD8+ T-cells can produce immune mediators in response to viral antigens
2018
·
Ritah Nakiboneka
, Susan Mugaba
, et al.
·
Vaccine
·
36
PDF
Safety and broad immunogenicity of HIVconsvX conserved mosaic candidate T-cell vaccines vectored by ChAdOx1 and MVA in HIV-CORE 006: a double-blind, randomised, placebo-controlled phase 1 trial in healthy adults living without HIV-1 in eastern and southern Africa
2025
·
Chama Chanda
, Freddie Kibengo
, et al.
·
The Lancet Microbe
·
14
PDF
Seroprevalence and durability of antibody responses to AstraZeneca vaccination in Ugandans with prior mild or asymptomatic COVID-19: implications for vaccine policy
2023
·
Jennifer Serwanga
, Claire Baine
, et al.
·
Frontiers in Immunology
·
13
PDF
Pre-pandemic SARS-CoV-2-specific IFN-γ and antibody responses were low in Ugandan samples and significantly reduced in HIV-positive specimens
2023
·
Hellen Nantambi
, Jackson Sembera
, et al.
·
Frontiers in Immunology
·
11
PDF
Profile of T Cell Recognition of HIV Type 1 Consensus Group M Gag and Nef Peptides in a Clade A1- and D-Infected Ugandan Population
2011
·
Jennifer Serwanga
, Susan Mugaba
, et al.
·
AIDS Research and Human Retroviruses
·
11
Sustained S-IgG and S-IgA antibodies to Moderna’s mRNA-1273 vaccine in a Sub-Saharan African cohort suggests need for booster timing reconsiderations
2024
·
Jennifer Serwanga
, Violet Ankunda
, et al.
·
Frontiers in Immunology
·
10
Examining oral pre-exposure prophylaxis (PrEP) literacy among participants in an HIV vaccine trial preparedness cohort study
2022
·
Rujeko Samanthia Chimukuche
, Rachel Kawuma
, et al.
·
BMC Health Services Research
·
10
PDF
Frequencies of Gag-restricted T-cell escape “footprints” differ across HIV-1 clades A1 and D chronically infected Ugandans irrespective of host HLA B alleles
2015
·
Jennifer Serwanga
, Ritah Nakiboneka
, et al.
·
Vaccine
·
7
PDF
Coreceptor and Cytokine Concentrations May Not Explain Differences in Disease Progression Observed in HIV-1 Clade A and D Infected Ugandans
2011
·
Edward Wright
, Susan Mugaba
, et al.
·
PLoS ONE
·
7
PDF
Bacterial microbiome and host inflammatory gene expression in foreskin tissue
2023
·
Brandon S. Maust
, Stefan Petkov
, et al.
·
Heliyon
·
6
Short-term oral pre-exposure prophylaxis against HIV-1 modulates the transcriptome of foreskin tissue in young men in Africa
2022
·
Stefan Petkov
, Carolina Herrera
, et al.
·
Frontiers in Immunology
·
6
A randomized clinical trial of on-demand oral pre-exposure prophylaxis does not modulate lymphoid/myeloid HIV target cell density in the foreskin
2023
·
Cosnet L. Rametse
, Emily L. Webb
, et al.
·
AIDS
·
5
Assessment of a diverse panel of transmitted/founder HIV-1 infectious molecular clones in a luciferase based CD8 T-cell mediated viral inhibition assay
2022
·
Natalia Fernandez
, Peter Hayes
, et al.
·
Frontiers in Immunology
·
5
PDF
Mobilization of systemic CCL4 following HIV pre-exposure prophylaxis in young men in Africa
2022
·
Stefan Petkov
, Carolina Herrera
, et al.
·
Frontiers in Immunology
·
5
PDF
Spike protein is a key target for stronger and more persistent T-cell responses—a study of mild and asymptomatic SARS-CoV-2 infection
2023
·
Ivan Ssali
, Susan Mugaba
, et al.
·
International Journal of Infectious Diseases
·
4
PDF
CD8+T-Cell Responses before and after Structured Treatment Interruption in Ugandan Adults Who Initiated ART with CD4+T Cells <200 Cell/μL: The DART Trial STI Substudy
2011
·
Jennifer Serwanga
, Susan Mugaba
, et al.
·
AIDS Research and Treatment
·
4
PDF
BonoboFlow: viral genome assembly and haplotype reconstruction from nanopore reads
2024
·
Christian Ndekezi
, Drake Byamukama
, et al.
·
Bioinformatics Advances
·
3
PDF
Group M consensus Gag and Nef peptides are as efficient at detecting clade A1 and D cross-subtype T-cell functions as subtype-specific consensus peptides
2014
·
S. Mugaba
, R. Nakiboneka
, et al.
·
Vaccine
·
2
Practical guidelines for producing non-replicating canine adenovirus vectors
2026
·
Denis Omara
, Christian Ndekezi
, et al.
·
PLoS ONE
·
1
PDF
Validation of high-throughput oxford nanopore technology for HIV-1 transmitted/founder virus identification
2025
·
Drake Byamukama
, Christian Ndekezi
, et al.
·
International Journal of Infectious Diseases
·
1
PDF
Interferon-gamma Responses to HIV-1 Clade A and D Peptides in Ugandan Serodiscordant Couples - the CHAVI 002 Protocol
2008
·
Pietro Pala
, Edward Pimego
, et al.
·
AIDS Research and Human Retroviruses
·
1
Preclinical Safety Evaluation of a Replication-Defective Canine Adenovirus Type 2 Vector-Based SARS-CoV-2 Vaccine Candidate in Murine Models
2026
·
Denis Omara
, Christian Ndekezi
, et al.
·
Vaccines
Evolutionary dynamics of HIV-1 recombinants: analysis of contemporary and historical viral populations in East Africa
2026
·
Sheila N. Balinda
, Anne Kapaata
, et al.
·
Virology Journal
Validation of High-Throughput Oxford Nanopore Technology for HIV-1 Transmitted/Founder Virus Identification
2025
·
Drake Byamukama
, Christian Ndekezi
, et al.
·
SSRN Electronic Journal
Gene expression of tight junctions in foreskin is not affected by HIV pre-exposure prophylaxis
2024
·
Emily L. Webb
, Stefan Petkov
, et al.
·
Frontiers in Immunology
PDF
Show more works
View as search
Works count:
29
Citation count:
162
H-index:
7
I10-index:
7
Year
Topic
Type